Allogeneic chimeric antigen receptor cell therapies for cancer: progress made and remaining roadblocks

2024/11/15 by Caroline Diorio, David T. Teachey, Stephan A. Grupp · 1 voice · 1 citation
Biochemistry, Genetics and Molecular Biology · Engineering · Medicine · #CAR-T cell therapy research #CRISPR and Genetic Engineering #Nanowire Synthesis and Applications

paper · doi:10.1038/s41571-024-00959-y

crossref issued 2024/11/15 · crossref published 2024/11/15 · crossref published-online 2024/11/15 · openalex publication_date 2024/11/15 · crossref created 2024/11/15 · crossref deposited 2024/12/18 · crossref published-print 2025/01/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/29 · crossref indexed 2026/08/01

Citations

• Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia

Cited by

• Machine learning in AIRR diagnostics: Advances and applications

Discussions

• Our #TranslationalMedicine link of the week, chosen by @swog.org's Lee Ellis, MD, & Jimmy Rae, PhD: Allogeneic Chimeric Antigen Receptor Cell Therapies for Cancer: Progress Made and Remaining Roadbloc [bsky, 1 points, 0 comments]